{"id":15602,"date":"2021-10-05T11:49:51","date_gmt":"2021-10-05T11:49:51","guid":{"rendered":"https:\/\/clinlabint.com\/?p=15602"},"modified":"2021-10-05T11:49:51","modified_gmt":"2021-10-05T11:49:51","slug":"ziath-expands-operations-opens-eu-office","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/ziath-expands-operations-opens-eu-office\/","title":{"rendered":"Ziath expands operations, opens EU office"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Ziath expands operations, opens EU office<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

As a result of strong business growth over the last few years \u2013 sample management specialists \u2013 Ziath has made a new strategic investment to further support its expanding international operations.<\/h3>\n

<\/p>\n

To enhance the level of support to its growing customer base in the European Union \u2013 Ziath has opened a new office near Maastricht, Netherlands. The new Ziath BV office will be headed up by Wilbert Lennartz, a seasoned sales and marketing manager who aims to further expand Ziath\u2019s coverage with direct sales and knowledgeable support to customers across the Benelux region and Northern part of France. Beneficially for EU-based customers, the new Ziath BV office will be able to accept and process orders and payments forthe company\u2019s market-leading sample management solutions with unimpeded efficiency and lower costs in the post-Brexit market.<\/p>\n

Ziath Managing Director Neil Benn commented: “We are very pleased to have opened our third subsidiary company in the vital European drug discovery and biobanking market. This follows the success of our USA and Japan operations. We believe that Ziath BV will eventually grow to become a major European hub for supplying and supporting our customers within the EU as we continue to expand and launch new and ever more innovative products that simplify the science of sample management in the key areas of life science, drug discovery and biobanking.\u201d<\/p>\n<\/div><\/section>
\n